ClearPoint Neuro Inc.
CLPT
Positions held
Your positionsCLPT isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $319.99M | Enterprise value | $354.57M | Trailing P/E | — | Forward P/E | -8.78 |
| PEG | 0.61 | Price / book | 29.72 | Beta | 1.29 | Dividend yield | 0.00% |
| Revenue growth | 18.1% | Earnings growth | — | Gross margin | 62.6% | Operating margin | -94.2% |
| Profit margin | -81.8% | ROE | -2.3% | ROA | -24.4% | Debt / equity | 5.93 |
| Current ratio | 4.75 | Free cash flow | -$14.05M | Analyst recommendation | strong_buy | Mean target | $23.50 |
| 52w high | $29.35 | 52w low | $8.27 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $10.9M | $12.1M | $10.4M | $8.9M | $9.2M | — |
| Op margin | -94.2% | -69.9% | -67.7% | -59.5% | -61.6% | — |
| Net income | -$11.3M | -$9.6M | -$7.8M | -$5.9M | -$5.8M | — |
| Gross margin | 61.7% | 64.0% | 61.5% | 63.2% | 60.3% | — |
| Gross profit | $6.7M | $7.8M | $6.4M | $5.6M | $5.6M | — |
| Operating income | -$10.2M | -$8.5M | -$7.0M | -$5.3M | -$5.7M | — |
- Revenue -10% vs prior quarter ($11M vs $12M).
- Gross margin 61.7% (was 64% prior quarter).
- Operating margin compressed to -94.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $37.0M | $31.4M | $24.0M | $20.6M | — |
| Op margin | -65.4% | -62.9% | -93.7% | -79.5% | — |
| Net income | -$25.5M | -$18.9M | -$22.1M | -$16.4M | — |
| Gross margin | 61.4% | 60.9% | 56.8% | 65.8% | — |
| Gross profit | $22.7M | $19.1M | $13.6M | $13.5M | — |
| Operating income | -$24.2M | -$19.7M | -$22.4M | -$16.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
2026-09-29 · ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
2026-09-14 · Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
2026-09-04 · ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
2026-08-11 · ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
2026-08-04 · ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
2026-08-03 · ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
2026-08-03 · ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
2026-08-03 · ClearPoint Neuro Q2 Earnings Call Highlights
2026-08-03 · ClearPoint Neuro Reports Second Quarter 2026 Results
2026-07-31 · Earnings To Watch: ClearPoint Neuro Inc (CLPT) Q2 2026 -- GF Value Sees 28% Upside
Price (daily)
Full chart · RSI · MACD · patterns